Alerta De Seguridad para COCHLEAR IMPLANT. . Cochlear implants are medical devices that convert sound signals into electrical signals, which allow direct stimulation of the auditory nerve fibers through an electrode implanted in the cochlea.

Según Agência Nacional de Vigilância Sanitária (ANVISA), este evento ( alerta de seguridad ) involucró a un dispositivo médico en Brazil que fue producido por N/A.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Safety alert
  • ID del evento
  • Fecha
  • País del evento
  • Fuente del evento
  • URL de la fuente del evento
  • Notas / Alertas
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Notas adicionales en la data
    Following these events, one of the cochlear implant manufacturers of ADVANCED BIONICS CORPORATION voluntarily suspended the commercialization of the AB-5100 H11 (Hifocus I electrode) and AB-5100 H12 (HiFocus II electrode) of the CLARION brand. BRAZIL - August 23, 2002 - The National Agency of Sanitary Surveillance / ANVISA, has detected the existence of a similar product registered in Brazil and is investigating if there is any relation of this with the aforementioned product.
  • Causa
    The national institute of pharmacy and medicines (infarmed) was aware of the occurrence of 25 reports worldwide (with a higher incidence in europe) of bacterial meningitis potentially associated with the use of this product.
  • Acción
    In order to safeguard Public Health and to prevent the occurrence of bacterial meningitis in individuals with cochlear implants, INFARMED recommends that: "Centers responsible for implanting this type should inform individuals with cochlear implants (or their parents, in the case of of the main signs and symptoms of meningitis and that the same individuals are urged that if they detect the presence of the same signs or symptoms, urgently contact their attending physician and also that the history of vaccination for pneumococci and Haemophilus influenzae serotype B and that, if it has not been done, the hypothesis of vaccination of the individuals with cochlear implants, as well as the candidates to carry out this type of intervention be considered "


  • Source